3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
5
Ovarian Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Sarcoma, Kaposi
1
Rectal Neoplasms
1
Oesophagogastric Cancer
1
Non-small Cell Lung Cancer Metastatic
1
Metastatic Colorectal Cancer With Left-sided Primary Tumor
1
Meningeal Carcinomatosis
1
HER-2 Negative Breast Cancer
1
EGFR Positive Non-small Cell Lung Cancer
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colorectal Cancer Liver Metastasis
1
Advanced Primary Liver Cancer
1
Adenocarcinoma of Lung
1
Interventions
Neoadjuvant Therapy
1
Lapatinib
1
Epirubicin
1
Cisplatin
1
Chemotherapy, Adjuvant
1
Capecitabine
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Oesophagogastric Cancer
×
Bevacizumab
×
Clear all
NCT00450203
2016-12-01
ST03
Medical Research Council
Phase 2/3
Unknown
1,103 enrolled